Hollencrest Capital Management’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$22.3K	Sell	1,000 -2,000	-67%	-$47.8K	﹤0.01%	701
2025 Q4	$80.1K	Sell	3,000 -3,500	-54%	-$83.6K	﹤0.01%	477
2025 Q3	$139K	Hold	6,500	–	–	0.01%	375
2025 Q2	$140K	Hold	6,500	–	–	0.01%	340
2025 Q1	$108K	Buy	6,500 +5,000	+333%	+$90.8K	﹤0.01%	366
2024 Q4	$27.5K	Hold	1,500	–	–	﹤0.01%	626
2024 Q3	$23.1K	Hold	1,500	–	–	﹤0.01%	655
2024 Q2	$24.4K	Hold	1,500	–	–	﹤0.01%	632
2024 Q1	$27.7K	Hold	1,500	–	–	﹤0.01%	581
2023 Q4	$47K	Hold	1,500	–	–	﹤0.01%	499
2023 Q3	$31.3K	Hold	1,500	–	–	﹤0.01%	547
2023 Q2	$35.9K	Hold	1,500	–	–	﹤0.01%	544
2023 Q1	$28.2K	Hold	1,500	–	–	﹤0.01%	572
2022 Q4	$23.9K	Buy	+1,500	New	+$23.4K	﹤0.01%	578
2018 Q1	–	Sell	-7,985	Closed	-$241K	–	332
2017 Q4	$241K	Hold	7,985	–	–	0.03%	240
2017 Q3	$301K	Hold	7,985	–	–	0.04%	223
2017 Q2	$222K	Sell	7,985 -1,000	-11%	-$29.8K	0.03%	254
2017 Q1	$309K	Sell	8,985 -600	-6%	-$21.2K	0.05%	242
2016 Q4	$277K	Sell	9,585 -17	-0.2%	-$450	0.04%	226
2016 Q3	$305K	Sell	9,602 -3,000	-24%	-$102K	0.04%	241
2016 Q2	$409K	Buy	12,602 +532	+4%	+$17.8K	0.06%	213
2016 Q1	$337K	Sell	12,070 -2,000	-14%	-$43.6K	0.06%	229
2015 Q4	$501K	Buy	14,070 +1,017	+8%	+$35.8K	0.09%	189
2015 Q3	$432K	Buy	13,053 +207	+2%	+$8.61K	0.07%	187
2015 Q2	$538K	Sell	12,846 -207	-2%	-$8.01K	0.08%	179
2015 Q1	$425K	Hold	13,053	–	–	0.06%	221
2014 Q4	$414K	Sell	13,053 -17,932	-58%	-$509K	0.05%	239
2014 Q3	$767K	Sell	30,985 -19,000	-38%	-$444K	0.11%	133
2014 Q2	$1.13M	Sell	49,985 -7,000	-12%	-$146K	0.15%	107
2014 Q1	$1.39M	Hold	56,985	–	–	0.21%	94
2013 Q4	$1.42M	Buy	+56,985	New	+$1.34M	0.23%	86